CPT code 20220 is a medical code used to describe a bone biopsy procedure performed with a trocar or needle.
CPT code 20220 is used for a bone biopsy procedure where a trocar or needle is utilized to extract a sample of bone tissue for diagnostic purposes. This code is typically used by healthcare providers to document and bill for the service of obtaining a bone sample to investigate conditions such as infections, cancers, or other bone-related diseases.
When billing for CPT code 20220 (Bone biopsy, trocar/needle), it is essential to consider the appropriate use of modifiers to ensure accurate reimbursement and compliance with payer requirements. Below is a list of potential modifiers that could be used with CPT code 20220, along with the reasons for their use:
1. Modifier 26 - Professional Component
- Used when only the professional component of the service is being billed, such as the interpretation of the biopsy results.
2. Modifier TC - Technical Component
- Used when only the technical component of the service is being billed, such as the use of the equipment and supplies for the biopsy.
3. Modifier 50 - Bilateral Procedure
- Used if the bone biopsy is performed on both sides of the body during the same session.
4. Modifier 59 - Distinct Procedural Service
- Used to indicate that the bone biopsy is a distinct service from other procedures performed on the same day.
5. Modifier RT - Right Side
- Used to specify that the bone biopsy was performed on the right side of the body.
6. Modifier LT - Left Side
- Used to specify that the bone biopsy was performed on the left side of the body.
7. Modifier 76 - Repeat Procedure by Same Physician
- Used if the same physician repeats the bone biopsy procedure on the same day.
8. Modifier 77 - Repeat Procedure by Another Physician
- Used if a different physician repeats the bone biopsy procedure on the same day.
9. Modifier 78 - Unplanned Return to the Operating/Procedure Room by the Same Physician Following Initial Procedure for a Related Procedure During the Postoperative Period
- Used if the patient needs to return to the operating room for a related procedure during the postoperative period.
10. Modifier 79 - Unrelated Procedure or Service by the Same Physician During the Postoperative Period
- Used if the bone biopsy is performed during the postoperative period of another, unrelated procedure.
11. Modifier 91 - Repeat Clinical Diagnostic Laboratory Test
- Used if the bone biopsy needs to be repeated for clinical diagnostic purposes.
By appropriately applying these modifiers, healthcare providers can ensure that their claims for CPT code 20220 are processed correctly and that they receive accurate reimbursement for the services provided.
When determining if a specific CPT code, such as 20220 (Bone biopsy trocar/needle), is reimbursed by Medicare, it is essential to consult the Medicare Physician Fee Schedule (MPFS) and Local Coverage Determinations (LCDs) provided by Medicare Administrative Contractors (MACs).
For CPT code 20220, Medicare does provide reimbursement, but the amount can vary based on geographic location and other factors. As of the latest update, the national average reimbursement rate for CPT code 20220 is approximately $200. However, this amount can differ based on the specific locality adjustments and other considerations.
To obtain the most accurate and up-to-date reimbursement information, healthcare providers should refer to the MPFS and check with their respective MACs. Additionally, it is advisable to verify any specific documentation requirements or coverage limitations that may apply to ensure compliance and optimize reimbursement.
Discover how MD Clarity's RevFind software can meticulously read your contracts and detect underpayments down to the CPT code level and by individual payer. Ensure you're receiving accurate reimbursements for procedures like CPT code 20220 (Bone biopsy trocar/needle). Schedule a demo today to see how RevFind can optimize your revenue cycle management.
Get paid in full by bringing clarity to your revenue cycle
Subscribe to the
Healthcare Clarified newsletter
Get the latest insights on RCM and healthcare policy in your inbox
